{"transactions":[{"id":3625574,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":159722,"kind":"person","name":"Matis Louis","position":1,"cik":"0001650991","reported_name":"Matis Louis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-28T22:25:09.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":96500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on February 26, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter."}],"balance_after":96500,"derivative":{"exercise_price":3.09,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":96500},"source":{"system":"sec-edgar","filing":"0001562180-19-001488","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218019001488/primarydocument.xml","form_type":"4"}},{"id":4032985,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":159722,"kind":"person","name":"Matis Louis","position":1,"cik":"0001650991","reported_name":"Matis Louis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2018-02-27T00:16:10.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on January 1, 2019 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter."}],"balance_after":100000,"derivative":{"exercise_price":8.56,"expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-18-001253","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218018001253/primarydocument.xml","form_type":"4"}},{"id":4399822,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":159722,"kind":"person","name":"Matis Louis","position":1,"cik":"0001650991","reported_name":"Matis Louis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (Right to buy)","published_at":"2017-03-06T11:50:36.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the option shares on January 1, 2018 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter."}],"balance_after":145000,"derivative":{"exercise_price":1.99,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0000899243-17-006558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000089924317006558/doc4.xml","form_type":"4"}}]}